Image de couverture de livre

Letter: Enhancing cirrhosis management—The critical role of social workers in supporting NAFLD surveillance

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Senlin Ye, Jinli Liu, Ruyi Zhou
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Alimentary Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Editorial: NAFLD, NAFLD, or MASLD: what's in a name?
par: Maryam Zafer, et autres
Publié: (2024)

Letter: Enhancing patient support through social work—Addressing economic challenges and medication non‐adherence in liver disease management
par: Min Wu, et autres
Publié: (2024)

Letter: Bisphosphonate effectiveness in patients with cirrhosis—An emulated clinical trial
par: Mingsi Zhang, et autres
Publié: (2024)

Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed
par: Haibo Jing, et autres
Publié: (2024)

Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed. Authors' reply
par: Andrea Martini, et autres
Publié: (2024)

Letter: Bisphosphonate effectiveness in patients with cirrhosis—an emulated clinical trial. Authors' reply
par: Elliot B. Tapper, et autres
Publié: (2024)

Review article: Evaluation and care of the critically ill patient with cirrhosis
par: Iva Kosuta, et autres
Publié: (2024)

Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D
par: Jian Wang, et autres
Publié: (2024)

Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find
par: Leya Nedumannil, et autres
Publié: (2024)

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis—Authors' reply
par: Lukas Burghart, et autres
Publié: (2024)

Editorial: Non‐selective beta‐blockers: A lifesaving shield for critically ill patients with acute decompensation of cirrhosis?
par: Ling Yang, et autres
Publié: (2024)

Review article: Recent advances in ascites and acute kidney injury management in cirrhosis
par: Danielle Adebayo, et autres
Publié: (2024)

Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find. Author's reply
par: Sagnik Biswas, et autres
Publié: (2024)

Non‐selective beta‐blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real‐world study
par: Rahul Kumar, et autres
Publié: (2024)

Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial
par: Elliot B. Tapper, et autres
Publié: (2024)

Editorial: Revisit the causes and long‐term outcomes in cirrhosis patients
par: Ming‐Lun Yeh, et autres
Publié: (2024)

Editorial: Terlipressin and MDRO colonisation in cirrhosis—Is there a causal link?
par: Luciano Revelli, et autres
Publié: (2024)

Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience—Authors' reply
par: Vibeke Strande, et autres
Publié: (2024)

Letter: Enhancing gastric cancer prevention—The need for a comprehensive three‐tier emergency management strategy. Authors' reply
par: Irene Ligato, et autres
Publié: (2024)

Letter: The multifaceted role of Escherichia coli in influencing disorders of industrial populations
par: Maria Rosa Ingrosso, et autres
Publié: (2024)

Editorial: Revisit the causes and long‐term outcomes in cirrhosis patients—Authors' reply
par: Linda Henry, et autres
Publié: (2024)

Editorial: Novel insights into the prognostic relevance of high‐dose PPI treatment in patients with cirrhosis
par: Dominik Bettinger, et autres
Publié: (2024)

Letter: Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
par: Zhidong Zhou, et autres
Publié: (2025)

Letter: Reflections on the role of over‐the‐scope clips in high‐risk upper gastrointestinal bleeding
par: Yajie Wang, et autres
Publié: (2024)

Letter: Post‐endoscopic management after upper gastrointestinal bleeding—Replenishment of iron loss
par: Palle Bager, et autres
Publié: (2024)

Terlipressin therapy is associated with increased risk of colonisation with multidrug‐resistant bacteria in patients with decompensated cirrhosis
par: Marcus M. Mücke, et autres
Publié: (2024)

Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease
par: R. M. Mathias, et autres
Publié: (2024)

The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes
par: Lana Bridi, et autres
Publié: (2024)

Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2–F3 fibrosis
par: Yusuf Yilmaz
Publié: (2024)

Letter: Selective FGFR1c/KLB Activation in MASH—A Mechanistic Dilemma?
par: Cuiyun Tao, et autres
Publié: (2025)

Repeatability of vibration‐controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study
par: Harris Siddiqi, et autres
Publié: (2024)

Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality
par: Lukas Hartl, et autres
Publié: (2024)

Letter: Resmetirom for treatment of MASH with children and adolescents
par: Yong‐Hai Zhou, et autres
Publié: (2024)

Letter: Incremental Value and Stratified Interpretation of Dual Autoantibody Positivity in Primary Biliary Cholangitis
par: Ao Gao, et autres
Publié: (2026)

Impact of non‐selective beta blockers on further decompensation and death in decompensated cirrhosis: Benefit and risk stratification by MELD score
par: Ting Wang, et autres
Publié: (2024)

Prevalence and prognosis of patients with MASLD ‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study
par: Philippe Sultanik, et autres
Publié: (2024)

Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection
par: Lisa Sandmann, et autres
Publié: (2024)

Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2‐F3 fibrosis. Authors' reply
par: Stuart McPherson, et autres
Publié: (2024)

Letter: Enhancing Risk‐Adapted Colorectal Cancer Screening for People With Diabetes—Authors' Reply
par: Teresa Seum, et autres
Publié: (2025)

Letter: Myokines Are Also Associated With Disease Course in Primary Biliary Cholangitis
par: Leyu Zhou, et autres
Publié: (2024)